| Medicinal product name | Tonzirin 8.75 mg lozenges |
||||||
|---|---|---|---|---|---|---|---|
| Pharmaceutical form | Lozenge | ||||||
| Strength | 8.75 mg | ||||||
| Information from the MAH on shortages | No information on expected shortages | ||||||
| Availability of medicinal product |
|
||||||
| Legal status | OTC | ||||||
| Package leaflet |  14-12-2023
|
||||||
| Summary of product characteristics | 14-12-2023
|
||||||
| ATC code | R02AX01 – Throat preparations | ||||||
| Information for Marketing authorisation holders | View |
Medicinal products (5)
| Availability of medicinal product | Wholesalers | Package size, content | Primary packaging | Maximum admissible pharmacy price (€ incl. VAT) | Product No. | Labelling |
|---|---|---|---|---|---|---|
| Not available (according to the information provided by wholesalers) | currently no information on availability from any wholesaler |
N8 (8,75 mg) |
PVC/PVDC/Al blister | 21-0095-01 |
Labelling text May 16, 2023 Labelling text May 16, 2023 |
|
| Not available (according to the information provided by wholesalers) | currently no information on availability from any wholesaler |
N12 (8,75 mg) |
PVC/PVDC/Al blister | 21-0095-02 |
Labelling text Jan 10, 2023 Labelling text Jan 10, 2023 |
|
| Not available (according to the information provided by wholesalers) | currently no information on availability from any wholesaler |
N16 (8,75 mg) |
PVC/PVDC/Al blister | 21-0095-03 |
Labelling text Jan 10, 2023 Labelling text Jan 10, 2023 |
|
| Not available (according to the information provided by wholesalers) | currently no information on availability from any wholesaler |
N20 (8,75 mg) |
PVC/PVDC/Al blister | 21-0095-04 |
Labelling text Jan 10, 2023 Labelling text Jan 10, 2023 |
|
|
Is available (according to the information provided by wholesalers) (1804 containers) |
Recipe Plus |
N24 (8,75 mg) |
PVC/PVDC/Al blister | € 10.98 | 21-0095-05 |
Labelling text Jan 10, 2023 Labelling text Jan 10, 2023 |
Registration information
| Marketing authorisation No. | 21-0095 |
|---|---|
| Date of authorisation | Jun 7, 2021 |
| Marketing authorisation holder, country | Inteli Generics Nord UAB, Lithuania |
